MRK : Summary for Merck & Company, Inc. Common St - Yahoo Finance

U.S. Markets close in 13 mins.

Merck & Co., Inc. (MRK)

NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
65.85-0.31 (-0.47%)
As of 3:47PM EST. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close66.16
Bid0.00 x
Ask0.00 x
Day's Range65.56 - 65.94
52 Week Range50.09 - 66.16
Avg. Volume10,955,783
Market Cap181.56B
PE Ratio (TTM)32.28
Earnings DateN/A
Dividend & Yield1.88 (2.84%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist10 minutes ago

    What Are Analysts’ Recommendations for Merck in 2017?

    For 2016, Merck & Co. (MRK) reported revenue close to $39.8 billion, a year-over-year (or YoY) rise of ~1%. New product launches have played major roles in boosting Merck’s 2016 revenue.

  • Reuters1 hour ago

    J&J says kept drug price increases below 10 pct since 2012

    Johnson & Johnson on Monday said the average list price of its drugs rose less than 10 percent each year since 2012, noting that the net price paid for the drugs, which includes discounts and rebates, was significantly lower. The company released a report with its price increase history in response to widespread outcry over high U.S. prices for prescription drugs. U.S. President Donald Trump has said drug companies are "getting away with murder" in what they charge the government for medicines.

  • Investopedia2 hours ago

    Cempra Skin Infection Drug Succeeds in Trial

    Cempra’s bacterial-skin infection pill did well in a late-study clinical trial.